Mary Kate Nguyen, age 37, from Brooklyn Park, Minnesota, originally from Vietnam, received the prison term after an April 23, 2023, guilty plea to one count of wire fraud and one count of contempt ...

BioMarin Pharmaceutical has made a couple of appointments aimed at boosting its pipeline, both internally and externally, with C-suite appointments in charge of R&D and business development.

BioMarin's has signed the first contract with an insurer in Germany for Roctavian, its recently approved gene therapy for haemophilia A, as it tests out its outcomes-based agreement (OBA ...

SAN RAFAEL, Calif., Jan. 13, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the company has initiated a legal action against Ascendis Pharma A/S for ...

BioMarin Pharmaceutical (BMRN) announced that the company has initiated a legal action against Ascendis Pharma (ASND) for infringement of European patent EP 3 175 863 B1 at the Unified Patent ...

Jefferies analyst Akash Tewari maintained a Buy rating on BioMarin Pharmaceutical (BMRN – Research Report) today and set a price target of $110.00. The company’s shares closed yesterday at $63.81.

San Rafael, CA-based BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for life-threatening severe medical conditions, mainly for children. BMRN sits at a ...